Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-15-037810
Filing Date
2015-10-16
Accepted
2015-10-16 10:15:15
Documents
1
Period of Report
2015-10-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5663
  Complete submission text file 0001140361-15-037810.txt   7068
Mailing Address AMGEN INC. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
Business Address
GLUCK FREDERICK W (Reporting) CIK: 0001184126 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37587 | Film No.: 151161280

Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Issuer) CIK: 0001501989 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations